Ebrahim Azizi Selected Research

Ebrahim Azizi Research Topics

Disease

12	Neoplasms (Cancer) 01/2019 - 10/2007
9	Breast Neoplasms (Breast Cancer) 01/2020 - 10/2010
6	Circulating Neoplastic Cells 01/2019 - 06/2016
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2020 - 01/2019
2	Lung Neoplasms (Lung Cancer) 01/2017 - 10/2013
2	Colorectal Neoplasms (Colorectal Cancer) 01/2013 - 10/2007
2	Melanoma (Melanoma, Malignant) 01/2013 - 10/2006
2	Carcinoma (Carcinomatosis) 03/2012 - 10/2011
1	Thrombophilia 10/2021
1	Venous Thromboembolism 10/2021
1	Activated Protein C Resistance (APC Resistance) 10/2021
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2021
1	Urinary Bladder Neoplasms (Bladder Cancer) 09/2020
1	Triple Negative Breast Neoplasms 01/2020
1	Anemia 10/2019
1	Hemoglobinopathies 10/2019
1	Thalassemia 10/2019
1	beta-Thalassemia (Cooley's Anemia) 10/2019
1	Prostatic Neoplasms (Prostate Cancer) 01/2019
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2017
1	Stomach Neoplasms (Stomach Cancer) 01/2014
1	Myeloid Leukemia (Leukemia, Myelocytic) 01/2013
1	Hyperglycemia 01/2013
1	Glioma (Gliomas) 01/2013
1	Fibrosarcoma 01/2013
1	Infections 06/2011
1	Malaria 06/2011
1	Transfusion Reaction 06/2011
1	Pulmonary Tuberculosis 01/2011
1	Carcinoid Tumor (Carcinoid) 01/2009
1	Adenocarcinoma 10/2007
1	Acute Erythroblastic Leukemia (Erythroleukemia) 10/2007
1	Skin Neoplasms (Skin Cancer) 10/2006

Drug/Important Bio-Agent (IBA)

5	Proteins (Proteins, Gene)FDA Link 01/2017 - 10/2006
5	Doxorubicin (Adriamycin)FDA LinkGeneric 07/2015 - 10/2007
4	graphene oxideIBA 01/2019 - 10/2013
3	RNA (Ribonucleic Acid)IBA 01/2020 - 09/2016
2	AntioxidantsIBA 09/2020 - 12/2012
2	Biomarkers (Surrogate Marker)IBA 01/2019 - 01/2017
2	Biological ProductsIBA 01/2016 - 12/2012
2	Pharmaceutical PreparationsIBA 04/2015 - 01/2011
2	Messenger RNA (mRNA)IBA 10/2011 - 10/2006
1	Protein CIBA 10/2021
1	factor V LeidenIBA 10/2021
1	Contraceptive Agents (Contraceptives)IBA 10/2021
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2021
1	Tumor Biomarkers (Tumor Markers)IBA 09/2020
1	Oxidants (Oxidizing Agents)IBA 09/2020
1	Reactive Oxygen Species (Oxygen Radicals)IBA 09/2020
1	Protein Isoforms (Isoforms)IBA 01/2020
1	ErbB Receptors (EGF Receptor)IBA 01/2020
1	Hemoglobin HIBA 10/2019
1	IronIBA 10/2019
1	Immune Checkpoint InhibitorsIBA 01/2019
1	Aldehyde DehydrogenaseIBA 01/2018
1	Epithelial Cell Adhesion MoleculeIBA 01/2017
1	PolymersIBA 06/2016
1	SuspensionsIBA 01/2016
1	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 01/2016
1	QuinolinesIBA 01/2016
1	QuercetinIBA 07/2015
1	Small Interfering RNA (siRNA)IBA 05/2015
1	2- (4- morpholinyl)- 8- phenyl- 4H- 1- benzopyran- 4- oneIBA 05/2015
1	Mitoxantrone (Novantrone)FDA LinkGeneric 05/2015
1	BerberineIBA 04/2015
1	Nicotine FDA Link 01/2014
1	CotinineIBA 01/2014
1	SmokeIBA 01/2014
1	GoldIBA 10/2013
1	caffeic acidIBA 01/2013
1	EstersIBA 01/2013
1	Glucose (Dextrose)FDA LinkGeneric 01/2013
1	Diazinon (Dimpylate)IBA 01/2013
1	caffeic acid phenethyl esterIBA 01/2013
1	Cyclin D1IBA 12/2012
1	PolyphenolsIBA 03/2012
1	fascinIBA 10/2011
1	ChitosanIBA 01/2011
1	Isoniazid (Ftivazide)FDA LinkGeneric 01/2011
1	Antitubercular AgentsIBA 01/2011
1	Irinotecan (Camptosar)FDA LinkGeneric 06/2010
1	Folic Acid (Vitamin M)FDA LinkGeneric 06/2010
1	Trypan Blue FDA Link 01/2009
1	Thymidine PhosphorylaseIBA 10/2007
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 10/2007
1	trioctyl phosphine oxide (TOPO)IBA 10/2007
1	Thymidylate SynthaseIBA 10/2007
1	Type II DNA Topoisomerases (Topoisomerase II)IBA 10/2007
1	Inhibitor of Apoptosis ProteinsIBA 10/2006
1	Cisplatin (Platino)FDA LinkGeneric 10/2006
1	OligonucleotidesIBA 10/2006
1	Antisense OligonucleotidesIBA 10/2006

Therapy/Procedure

5	Therapeutics 01/2019 - 10/2006
3	Drug Therapy (Chemotherapy) 07/2015 - 10/2007
2	Lab-On-A-Chip Devices 01/2017 - 01/2017
1	Oral Surgery (Maxillofacial Surgery) 10/2021
1	Castration 01/2019
1	Radiotherapy 01/2019
1	Perioperative Period 01/2017
1	Blood Transfusion (Blood Transfusions) 06/2011